Primate Info Net Banner Wisconsin PRC Logo


Current Topics in Primatology
Primate Information Center
Washington Regional Primate Research Center



Lentiviral Vaccine Research: 1998-1999

Allen TM; Sidney J; del Guercio MF; Glickman RL; Lensmeyer GL; Wiebe DA;
DeMars R; Pauza CD; Johnson RP; Sette A; Watkins DI
Characterization of the peptide binding motif of a rhesus MHC class I
molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian
immunodeficiency virus.
JOURNAL OF IMMUNOLOGY 160(12): 6062-6071, 1998.

Almond NM; Heeney JL
AIDS vaccine development in primate models.
AIDS 12 (Suppl A): S133-S140, 1998.

Arthur LO; Bess JW Jr; Chertova EN; Rossio JL; Esser MT; Benveniste RE;
Henderson LE; Lifson JD
Chemical inactivation of retroviral infectivity by targeting nucleocapsid
protein zinc fingers: A candidate SIV vaccine.
AIDS RESEARCH AND HUMAN RETROVIRUSES 14(Suppl 3): S-311-S-319, 1998.

Bagarazzi ML; Boyer JD; Ayyavoo V; Weiner DB
Nucleic acid-based vaccines as an approach to immunization against human
immunodeficiency virus type-1.
CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY 226: 107-143, 1998.

Bagarazzi ML; Boyer JD; Ugen KE; Javadian MA; Chattergoon M; Shah A;
Bennett M; Ciccarelli R; Carrano R; Coney L; Weiner DB
Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees.
VACCINE 16(19): 1836-1841, 1998.

Baltimore D; Heilman C
HIV vaccines: prospects and challenges.
SCIENTIFIC AMERICAN 279(1): 98-103, 1998.

Beardsley T
Lives in the balance: Researchers plan to modify HIV and try it as a live
AIDS vaccine.
SCIENTIFIC AMERICAN 278(4): 17-18, 1998.

Benson J; Chougnet C; Robert-Guroff M; Montefiori D; Markham P; Shearer G;
Gallo RC; Cranage M; Paoletti E; Limbach K; Venzon D; Tartaglia J;
Franchini G
Recombinant vaccine-induced protection against the highly pathogenic
simian immunodeficiency virus SIVmac251: Dependence on route of challenge
exposure.
JOURNAL OF VIROLOGY 72(5): 4170-4182, 1998.

Bergmeier LA; Mitchell EA; Hall G; Cranage MP; Cook N; Dennis M; Lehner T
Antibody-secreting cells specific for simian immunodeficiency virus
antigens in lymphoid and mucosal tissues of immunized macaques. AIDS
12(10): 1139-1147, 1998.

Burton DR; Moore JP
Why do we not have an HIV vaccine and how can we make one?
NATURE MEDICINE 4(5 suppl): 495-498, 1998.

Cheynier R; Gratton S; Halloran M; Stahmer I; Letvin NL; Wain-Hobson S
Antigenic stimulation by BCG vaccine as an in vivo driving force for SIV
replication and dissemination.
NATURE MEDICINE 4(4): 421-427, 1998.

Coeffier E; Girard M; Barre-Sinoussi F; Meignier B; Muchmore E; Fultz PN;
LeClerc C
Fine specificity of anti-V3 antibodies induced in chimpanzees by HIV
candidate vaccines.
AIDS RESEARCH AND HUMAN RETROVIRUSES 14(12): 1023-1034, 1998.

Cohen J
NIH concocts a booster shot for HIV vaccines.
SCIENCE 281(5381): 1270-1 & 1273, 1998.

Connor RI; Montefiori DC; Binley JM; Moore JP; Bonhoeffer S; Gettie A;
Fenamore EA; Sheridan KE; Ho DD; Dailey PJ; Marx PA
Temporal analyses of virus replication, immune responses, and efficacy in
rhesus macaques immunized with a live, attenuated simian immunodeficiency
virus vaccine.
JOURNAL OF VIROLOGY 72(9): 7501-7509, 1998.

Cranage MP; Sharpe SA; Whatmore AM; Polyanskaya N; Norley S; Cook N; Leech
S; Dennis MJ; Hall GA
In vivo resistance to simian immunodeficiency virus superinfection depends
on attenuated virus dose. JOURNAL OF GENERAL VIROLOGY 79 (8): 1935-1944,
1998.
          
Desrosiers, R; Lifson, JD; Gibbs, JS; Czajak, SC; Howe, AYM; Arthur, L O;
Johnson, R P
Identification of highly attenuated mutants of simian immunodeficiency
virus.
JOURNAL OF VIROLOGY 72(2): 1431-1437, 1998.

Di Fabio, S; Medaglini, D; Rush, CM; Corrias, F; Panzini, GL; Pace, M;
Verani, P; Pozzi, G; Titti, F
Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii
expressing HIV-1 and HPV 16 antigens. VACCINE 16(5): 485-492, 1998.

Farthing, C F
SIV vaccine for AIDS. SCIENCE 279(5347): 14-15, 1998. (Letter)

Gauduin MC; Glickman RL; Means R; Johnson RP
Inhibition of simian immunodeficiency virus (SIV) replication by CD8+ T
lymphocytes from macaques immunized with live attenuated SIV.
JOURNAL OF VIROLOGY 72(8): 6315-6324, 1998.

Geretti AM; Hulskotte E; Osterhaus ADME
Cytotoxic T lymphocytes in AIDS pathogenesis: Lessons to be learned from
the macaque model of simian immunodeficiency virus infection.
JOURNAL OF GENERAL VIROLOGY 79(3): 415-421, 1998.

Girard M; Mahoney J; Wei Q; van der Ryst E; Muchmore E; Barre-Sinoussi F;
Fultz PN
Genital infection of female chimpanzees with human immunodeficiency virus
type 1.
AIDS RESEARCH AND HUMAN RETROVIRUSES 14(15): 1357-1367, 1998.

Gottlieb S
Where now for AIDS vaccines? BMJ [BR MED J] 317(7152): 163, 1998.

Gregoriadis G
Genetic vaccines: Strategies for optimization.
PHARMACEUTICAL RESEARCH 15(5): 661-670, 1998.

Gundlach BR; Reiprich S; Sopper S; Means RE; Dittmer U; Maetz-Rensing K;
Stahl-Hennig C; Ueberla K
Env-independent protection induced by live, attenuated simian
immunodeficiency virus vaccines. JOURNAL OF VIROLOGY 72(10): 7846-7851,
1998.

Haga T; Kuwata T; Ui M; Igarashi T; Miyazaki Y; Hayami M
A new approach to AIDS research and prevention: The use of gene-mutated
HIV-1/SIV chimeric viruses for anti-HIV-1 live-attenuated vaccines.
MICROBIOLOGY AND IMMUNOLOGY 42(4): 245-251, 1998.

Heeney JL; Teeuwsen VJP; van Gils M; Bogers WMJM; de Giuli Morghen C;
Radaelli A; Barnett S; Morein B; Akerblom L; Wang YF; Lehner T; Davis D
Beta-chemokines and neutralizing antibody titers correlate with
sterilizing immunity generated in HIV-1 vaccinated macaques.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA 95(18):
10803-10808, 1998.

Heeney JL; van Gils ME; van der Meide P; de Giuli Morghen C; Ghioni C;
Gimelli M; Raddelli A; Davis D; Akerblom L; Morein B
The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine
protection.
JOURNAL OF MEDICAL PRIMATOLOGY 27(2/3): 50-58, 1998.

Heilman CA; Baltimore D
HIV vaccines: Where are we going? NATURE MEDICINE 4(5 suppl): 532-534,
1998.

Hulskotte EGJ; Geretti AM; Osterhaus ADME
Towards an HIV-1 vaccine: Lessons from studies in macaque models.
VACCINE 16(9-10): 904-915, 1998.

Igarashi T; Kuwata T; Yamamoto H; Moriyama H; Ui M; Miyazaki Y; Hayami M
Infectivity and immunogenicity of SIVmac/HIV-1 chimeric viruses (SHIVs)
with deletions in two or three genes (vpr, nef and vpx).
MICROBIOLOGY AND IMMUNOLOGY 42(1): 71-74, 1998.

Imaoka K; Miller CJ; Kubota M; McChesney MB; Lohman B; Yamamoto M;
Fujihashi K; Someya K; Honda M; McGhee JR; Kiyono H
Nasal immunization of nonhuman primates with simian immunodeficiency virus
p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific
immune responses in reproductive tissues. JOURNAL OF IMMUNOLOGY 161(11):
5952-5958, 1998.

          
Joag SV; Liu ZQ; Stephens EB; Smith MS; Kumar A; Li Z; Wang CY; Sheffer D;
Jia FL; Foresman L; Adany I; Lifson J; McClure HM; Narayan O
Oral immunization of macaques with attenuated vaccine virus induces
protection against vaginally transmitted AIDS. JOURNAL OF VIROLOGY 72(11):
9069-9078, 1998.

Johnson RP; Desrosiers RC
Protective immunity induced by live attenuated simian immunodeficiency
virus.
CURRENT OPINION IN IMMUNOLOGY 10(4): 436-443, 1998.

Kawabata, S; Miller, C J; Lehner, T; Fujihashi, K; Kubota, M; McGhee, J R;
Imaoka, K; Hiroi, T; Kiyono, H
Induction of Th2 cytokine expression for p27-specific IgA B cell responses
after targeted lymph node immunization with simian immunodeficiency virus
antigens in rhesus macaques. JOURNAL OF INFECTIOUS DISEASES 177(1): 26-33,
1998.

Kent SJ
Antiviral CD4 cell response in simian immunodeficiency virus-infected
macaques: Reply.
JOURNAL OF INFECTIOUS DISEASES 177(6): 1771-1772, 1998. (Letter)

Kim JJ
Rational vaccine design through the use of molecular adjuvants.
DISSERTATION ABSTRACTS INTERNATIONAL B59(4): 1764, 1998.
(To order: #AAD98-29927. University Microfilms, Inc, Ann Arbor, MI 48106)

Kim JJ; Nottingham LK; Wilson DM; Bagarazzi ML; Tsai A; Morrison LD;
Javadian A; Chalian AA; Agadjanyan MG; Weiner DB
Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes.
VACCINE 16(19): 1828-1835, 1998.

Kraus, G; Radaelli, A; Talbott, R; Leavitt, M; Schmidt, A; Badel, P;
Bartz, C; Morton, W; Wong-Staal, F; Looney, D J
Characterization of a molecular clone of HIV type 2 infectious for Macaca
nemestrina.
AIDS RESEARCH AND HUMAN RETROVIRUSES 14(1): 65-77, 1998.

Le Borgne, S; Mancini, M; Le Grand, R; Schleef, M; Dormont, D; Tiollais,
P; Riviere, Y; Michel, M-L
In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus
macaques immunized with DNA vector encoding an HIV epitope fused with
hepatitis B surface antigen. VIROLOGY 240(2): 304-315, 1998.

Lehner T; Wang Y; Cranage M; Bergmeier LA; Mitchell E; Tao L; Hall G;
Dennis M; Cook N; Jones I; Doyle C
Protective mucosal immunity elicited by targeted lymph node immunization
with a subunit SIV envelope and core vaccine in macaques.
DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION 92: 225-235, 1998.

Liu MA
Vaccine developments. NATURE MEDICINE 4(5 suppl): 515-519, 1998.

Looney DJ; McClure J; Kent SJ; Radaelli A; Kraus G; Schmidt A; Steffy K;
Greenberg P; Hu SL; Morton WR; Wong-Staal F
A minimally replicative HIV-2 live-virus vaccine protects M. nemestrina
from disease after HIV-2-287 challenge. VIROLOGY 242(1): 150-160, 1998.

Lu S
Developing DNA vaccines against immunodeficiency viruses.
CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY 226: 161-173, 1998.

Lu YC; Pauza CD; Lu XS; Montefiori DC; Miller CJ
Rhesus macaques that become systemically infected with pathogenic SHIV
89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make
an antiviral antibody response rapidly develop AIDS.
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
19(1): 6-18, 1998.

Lu, X-s; Kiyono, H; Lu, D; Kawabata, S; Torten, J; Srinivasan, S; Dailey,
P J; McGhee, J R; Lehner, T; Miller, C J
Targeted lymph-node immunization with whole inactivated simian
immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines
does not reliably protect rhesus macaques from vaginal challenge with
SIVmac251.
AIDS 12(1): 1-10, 1998.

McChesney MB; Collins JR; Miller CJ
Mucosal phenotype of antiviral cytotoxic T lymphocytes in the vaginal
mucosa of SIV-infected rhesus macaques.
AIDS RESEARCH AND HUMAN RETROVIRUSES 14(Suppl): S63-S66, 1998.

Meyer D; Anderson DE; Gardner MB; Torres JV
Hypervariable epitope constructs representing variability in envelope
glycoprotein of SIV induce a broad humoral immune response in rabbits and
rhesus macaques.
AIDS RESEARCH AND HUMAN RETROVIRUSES 14(9): 751-760, 1998.

Montefiori DC; Reimann KA; Wyand MS; Manson K; Lewis MG; Collman RG;
Sodroski JG; Bolognesi DP; Letvin NL
Neutralizing antibodies in sera from macaques infected with chimeric
simian-human immunodeficiency virus containing the envelope glycoproteins
of either a laboratory-adapted variant or a primary isolate of human
immunodeficiency
virus type 1. JOURNAL OF VIROLOGY 72(4): 3427-3431, 1998.

Mooij P; van der Kolk M; Bogers WMJM; ten Haaft PJF; Van Der Meide P;
Almond N; Stott J; Deschamps M; Labbe D; Momin P; Voss G; Von Hoegen P;
Bruck C; Heeney JL
A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from
in vivo passaged simian-human immunodeficiency virus infection.
AIDS 12(5): F15-F22, 1998.

Mortara, L; Letourneur, F; Gras-Masse, H; Venet, A; Guillet, J-G;
Bourgault-Villada, I
Selection of virus variants and emergence of virus escape mutants after
immunization with an epitope vaccine. JOURNAL OF VIROLOGY 72(2):
1403-1410, 1998.

Muller, S; Margolin, D H; Nara, P L; Alvord, W G; Kohler, H
Stimulation of HIV-1-neutralizing antibodies in simian HIV-IIIB-infected
macaques.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA 95(1): 276-281,
1998.

Murphey-Corb M; Wilson LA; Trichel AM; Roberts DE; Xu KY; Ohkawa S;
Woodson B; Bohm R; Blanchard J
Selective induction of protective MHC class I-restricted CTL in the
intestinal lamina propria of rhesus monkeys by transient SIV infection of
the colonic mucosa.
JOURNAL OF IMMUNOLOGY 162(1): 540-549, 1999.

Murthy KK; Cobb EK; Rouse SR; McClure HM; Payne JS; Salas MT; Michalek GR
Active and passive immunization against HIV type 1 infection in
chimpanzees.
AIDS RESEARCH AND HUMAN RETROVIRUSES 14(Suppl 3): S271-S276, 1998.

Nathanson N
Towards an AIDS vaccine: The role of primate models.
INTERNATIONAL JOURNAL OF STD & AIDS 9(Suppl 1): 3-7, 1998.

Navea L; Lobaina L; Dubed M; Alvarez G; Gomez C; Duarte C
[Study of the neutralizing activity of sera from immunized rhesus monkey
with a candidate Cuban vaccine: TAB9.]
BIOTECNOLOGIA APLICADA 15(3): 193-194, 1998. (Spanish)

Nilsson C; Makitalo B; Thorstensson R; Norley S; Binninger-Schinzel D;
Cranage M; Rud E; Biberfeld G; Putkonen P
Live attenuated simian immunodeficiency virus (SIV)mac in macaques can
induce protection against mucosal infection with SIVsm.
AIDS 12(17): 2261-2270, 1998.

Norley S; Beer B; Koenig H; Jensen F; Kurth R
SIVmac vaccine studies using whole inactivated virus antigen sequentially
depleted of viral proteins. JOURNAL OF MEDICAL PRIMATOLOGY 27(4): 184-192,
1998.

Palacios E; Digilio L; McClure HM; Chen ZW; Marx PA; Goldsmith MA; Grant
RM
Parallel evolution of CCR5-null phenotypes in humans and in a natural host
of simian immunodeficiency virus. CURRENT BIOLOGY 8(16): 943-946, 1998.

Pauza CD; Horejsh D; Wallace M
Mucosal transmission of virulent and avirulent lentiviruses in macaques.
AIDS RESEARCH AND HUMAN RETROVIRUSES 14(Suppl): S83-S87, 1998.

Petry H; Dittmer U; Jones D; Farrar G; Wachter H; Fuchs D; Nisslein T;
Jurkiewicz E; Hunsmann G; Stahl-Hennig C; Lueke W
Prechallenge high neutralizing antibodies and long-lasting immune
reactivity to gp41 correlate with protection of rhesus monkeys against
productive simian immunodeficiency virus infection or disease development.
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
19(5): 441-450, 1998.

Petry, H; Stahl-Hennig, C; Dittmer, U; Jones, D; Farrar, G; Wachter, H;
Fuchs, D; Nisslein, T; Jurkiewicz, E; Hunsmann, G; Lueke, W
A subunit vaccine consisting of gp130 oligomers but not of gp130 monomers
protects rhesus macaques against productive infection with SIVmac32H.
AIDS 12(3): 329-330, 1998. (Letter)

Putkonen P; Quesada-Rolander M; Leandersson AC; Schwartz S; Thorstensson
R; Okuda K; Wahren B; Hinkula J
Immune responses but no protection against SHIV by gene-gun delivery of
HIV-1 DNA followed by recombinant subunit protein boosts.
VIROLOGY 250(2): 293-301, 1998.

          
Radaelli A; Kraus G; Schmidt A; Badel P; McClure J; Hu SL; Morton W; de
Giuli Morghen C; Wong-Staal F; Looney D
Genetic variation in a human immunodeficiency virus type 2 live-virus
Macaca nemestrina vaccine model. JOURNAL OF VIROLOGY 72(10): 7871-7884,
1998.

Reitter JN; Means RE; Desrosiers RC
A role for carbohydrates in immune evasion in AIDS.
NATURE MEDICINE 4(6): 679-684, 1998.

Robert-Guroff M; Kaur H; Patterson LJ; Leno M; Conley AJ; McKenna PM;
Markham PD; Richardson E; Aldrich K; Arora K; Murty L; Carter L;
Zolla-Pazner S; Sinangil F
Vaccine protection against a heterologous, non-syncytium-inducing, primary
human immunodeficiency virus. JOURNAL OF VIROLOGY 72(12): 10275-10280,
1998.

Robinson JE; Cole KS; Elliott DH; Lam H; Amedee AM; Means R; Desrosiers
RC; Clements J; Montelaro RC; Murphey-Corb M
Production and characterization of SIV envelope-specific rhesus monoclonal
antibodies from a macaque asymptomatically infected with a live SIV
vaccine.
AIDS RESEARCH AND HUMAN RETROVIRUSES 14(14): 1253-1262, 1998.

Ruprecht RM; Baba TW; Liska V; Ayehunie S; Andersen J; Montefiori DC;
Trichel A; Morphey-Corb M; Martin L; Rizvi TA; Bernacky BJ; Buchl SJ;
Keeling M
Oral SIV, SHIV, and HIV type 1 infection.
AIDS RESEARCH AND HUMAN RETROVIRUSES 14(Suppl 1): S97-S103, 1998.

Schultz A
Encouraging vaccine results from primate models of HIV type 1 infection.
AIDS RESEARCH AND HUMAN RETROVIRUSES 14(Suppl 3): S261-S263, 1998.

Seth A; Ourmanov I; Kuroda MJ; Schmitz JE; Carroll MW; Wyatt LS; Moss B;
Forman MA; Hirsch VM; Letvin NL
Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus
gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a
major histocompatibility complex class I/peptide tetramer.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA 95(17):
10112-10116, 1998.

Sharpe SA
T cell responses to simian immunodeficiency virus.
DISSERTATION ABSTRACTS INTERNATIONAL C59(2): 365, 1998.

Stebbings R; Stott J; Almond N; Hull R; Lines J; Silvera P; Sangster R;
Corcoran T; Rose J; Cobbold S; Gotch F; McMichael A; Walker B
Mechanisms of protection induced by attenuated simian immunodeficiency
virus. II. Lymphocyte depletion does not abrogate protection.
AIDS RESEARCH AND HUMAN RETROVIRUSES 14(13): 1187-1198, 1998.

Steger KK
Pathogenesis of mucosally-transmitted chimeric simian/human
immunodeficiency virus (SHIV): Early effects on vaccine-induced immune
responses.
DISSERTATION ABSTRACTS INTERNATIONAL B59(1): 152, 1998.
(To order: #AAD97-36085. University Microfilms, Inc, Ann Arbor, MI 48106)

Stott EJ; Almond N; Kent K; Walker B; Hull R; Rose J; Silvera P; Sangster
R; Corcoran T; Lines J; Silvera K; Luciw P; Murphy-Corb M; Momin P; Bruck
C
Evaluation of a candidate human immunodeficiency virus type 1 (HIV 1)
vaccine in macaques: Effect of vaccination with HIV-1 gp120 on subsequent
challenge with heterologous simian immunodeficiency virus- HIV-1 chimeric
virus.
JOURNAL OF GENERAL VIROLOGY 79(Pt 3): 423-432, 1998.

Stott J; Hu SL; Almond N
Candidate vaccines protect macaques against primate immunodeficiency
viruses.
AIDS RESEARCH AND HUMAN RETROVIRUSES 14(Suppl): S265-S270, 1998.

Van der Ryst E; Nakasone T; Habel A; Venet A; Gomard E; Altmeyer R; Girard
M; Borman AM
Study of the immunogenicity of different recombinant Mengo viruses
expressing HIV1 and SIV epitopes. RESEARCH IN VIROLOGY 149(1): 5-20, 1998.
(French summary)

Vogel TU; Fournier J; Sherring A; Ko D; Parenteau M; Bogdanovic D;
Mihowich J; Rud EW
Presence of circulating CTL induced by infection with wild-type or
attenuated SIV and their correlation with protection from pathogenic SHIV
challenge.
JOURNAL OF MEDICAL PRIMATOLOGY 27(2/3): 65-72, 1998.

Wagner R; Teeuwsen VJP; Deml L; Notka F; Haaksma AGM; Jhagjhoorsingh SS;
Niphuis H; Wolf H; Heeney JL
Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by
virus-like particle HIV vaccines in the absence of protection from SHIV
infection.
VIROLOGY 245(1): 65-74, 1998.

Wang YF; Tao L; Mitchell E; Bogers WMJM; Doyle C; Bravery CA; Bergmeier
LA; Kelly CG; Heeney JL; Lehner T
Generation of CD8 suppressor factor and beta chemokines, induced by
xenogeneic immunization, in the prevention of simian immunodeficiency
virus infection in macaques.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
AMERICA 95(9): 5223-5228, 1998.

Warner JF; Jolly DJ; Merritt J
Human immunodeficiency virus immunotherapy using a retroviral vector.
CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY 226: 145-160, 1998.

Zolla-Pazner, S; Lubeck, M; Xu, S; Burda, S; Natuk, R J; Sinangil, F;
Steimer, K; Gallo, R C; Eichberg, J W; Matthews, T; Robert-Guroff, M
Induction of neutralizing antibodies to T-cell line-adapted and primary
human immunodeficiency virus type 1 isolates with a prime-boost vaccine
regimen in chimpanzees. JOURNAL OF VIROLOGY 72(2): 1052-1059, 1998.